作者: Masaaki Takahashi , Atsushi Hirano , Nami Okubo , Eri Kinoshita , Toshiharu Nomura
DOI: 10.2152/JMI.57.245
关键词:
摘要: Rilpivirine (TMC-278) is a second-generation non-nucleoside reverse transcriptase inhibitor that high potent against both wild-type and drug-resistant HIV-1 strains. Therefore, rilpivirine expected to treat therapy-experienced patients who failed use current drugs due the emergence of HIV mutants. The quantification in human plasma important support clinical studies determine pharmacokinetic parameters infected patients. Consequently, simple easy system concentrations has been required. In this study, we developed conventional LC-MS method quantify rilpivirine. Subsequently was validated by estimating precision accuracy for inter- intraday analysis concentration range 18-715 ng/ml. calibration curve linear range. Average ranged from 100.0 100.6%. Relative standard deviations assays were less than 3.3%. Recovery more 82.0%. These results demonstrate our provides conventional, accurate precise way plasma. This can be used routine application patients, permits management drug interactions toxicity